NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/04/2025
Voltar para busca
Dado oficial do USPTO
EXSCIENTIA DRIVEN BY KNOWLEDGE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
26/04/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 42, 44
Data de depósito
14/03/2022
Data de registro
09/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/01/2024
Última transação
26/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
GB
Examinador
SWIFT, GILBERT
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording, "EXSCIENTIA" over the wording, "DRIVEN BY KNOWLEDGE.
Titulares e representantes
Titulares
Exscientia AI Limited
Representantes
David Johnson Workman Nydegger
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of painviral diseasescoronavirusherpeshepatitiscancerlung cancerpancreatic cancerhaematological cancercolorectal cancerbreast cancerbladder cancercervical cancergynecologic cancerhead and neck cancerkidney cancerliver cancermyelomaovarian cancerprostate cancerskin cancerthyroid canceruterine cancerneurological cancermental and physical disorders and conditionsschizophreniamental health disorderseating disorders and addictionsnicotine addictionskin conditionsdermatitisskin pigmentation diseasespsoriasiseczemarespiratory infectionseye infectionsbacterial and parasitic infectionsmalaria and tuberculosisrespiratory conditionsanxietyarthritisneurological diseasesHuntington's diseasecerebral palsybrain injuryspinal cord injuryseizure disordersimmunologic diseases and disordersnamely Alzheimer'sParkinson's diseaseulcerative colitismultiples sclerosisimmuno-oncological diseasesatopic dermatitisasthmainflammatory bowel diseases (IBD)systemic lupus erythematosus (SLE)chronic obstructive pulmonary diseases (COPD)musculoskeletal diseasesbone diseasescentral nervous system (CNS) diseasesperipheral nervous system (PNS) diseasescardiovascular diseases and disorders; Medical preparations for the treatment of painviral diseasescoronavirusherpeshepatitiscancerlung cancerpancreatic cancerhaematological cancercolorectal cancerbreast cancerbladder cancercervical cancergynecologic cancerhead and neck cancerkidney cancerliver cancermyelomaovarian cancerprostate cancerskin cancerthyroid canceruterine cancerneurological cancermental and physical disorders and conditionsschizophreniamental health disorderseating disorders and addictionsnicotine addictionskin conditionsdermatitisskin pigmentation diseasespsoriasiseczemarespiratory infectionseye infectionsbacterial and parasitic infectionsmalaria and tuberculosisrespiratory conditionsanxietyarthritisneurological diseasesHuntington's diseasecerebral palsybrain injuryspinal cord injuryseizure disordersimmunologic diseases and disordersnamely Alzheimer'sParkinson's diseaseulcerative colitismultiples sclerosisimmuno-oncological diseasesatopic dermatitisasthmainflammatory bowel diseases (IBD)systemic lupus erythematosus (SLE)chronic obstructive pulmonary diseases (COPD)musculoskeletal diseasesbone diseasescentral nervous system (CNS) diseasesperipheral nervous system (PNS) diseasescardiovascular diseases and disorders; Veterinary preparations for the treatment of painviral diseasesparamyxovirusinfluenza A viruscoronavirusherpeshepatitiswoundscancerlung cancerpancreatic cancerhaematological cancercolorectal cancerbreast cancerbladder cancercervical cancergynecologic cancerhead and neck cancerkidney cancerliver cancermyelomaovarian cancerprostate cancerskin cancerthyroid canceruterine cancerneurological cancermental and physical disorders and conditionsmental health disordersmusculoskeletal diseasesbone diseasescentral nervous system (CNS) diseasescardiovascular diseases and disordersskin conditionsdermatitisskin pigmentation diseasespsoriasiseczemarespiratory infectionseye infectionsbacterial and parasitic infectionsmalaria and tuberculosisrespiratory conditionsarthritisinflammatory diseasesinflammatory bowel diseasesinflammatory connective tissue diseasesimmunologic diseases and disordersnamely Alzheimer'sulcerative colitisimmuno-oncological diseasesatopic dermatitisasthmainflammatory bowel diseases (IBD)systemic lupus erythematosus (SLE)chronic obstructive pulmonary diseases (COPD)allergiesanxiety; veterinary preparationsvaccines for animalssanitary substances for medical use for the treatment of autoimmune diseasesautoimmune diseasesspecifically psoriasisarthritisCrohn's disease; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary usefood for babies; dietetic substances in the nature of dietetic food adapted for medical or veterinary use; Dietary supplements for human beings and animals; plasters for medical purposes; materials for dressingsgauzebandages; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; pharmaceuticalveterinary and sanitary substances and preparationsantifungalsantiviralsherbicidesantibiotics
Classe 9
Downloadable computer software for analysis and interpretation of biological data using the combination of biologycomputer scienceinformation engineeringmathematics and statistics; Downloadable computer software for computer assisted molecule design; Downloadable computer software for chemical and biological research and analysis; Downloadable computer software for pharmaceutical research and development services; Downloadable computer software for diagnostic and screening servicesconducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes for use in the field of molecular research and to combat disease; downloadable computer software for use in the research and development of pharmaceutical products; downloadable computer software for cell analysis; downloadable computer software for the use in managing scientific projects; downloadable computer software for the design of chemical structures; downloadable computer software for the analysis of biological or chemical activity; downloadable artificial intelligence software for healthcarepharmaceuticals and diagnostics
Classe 42
Scientific and technological servicesscientific researchanalysistesting in the field of research and development of pharmaceutical products and molecule design and services relating thereto; industrial analysis and industrial research services in the field of research and development of pharmaceutical productsmolecule design and robotics for lab automation and industrial design services; quality control and authentication services in the field of works of scientific research for others; design and development of computer hardware and software; Bioinformatic servicesanalysis and interpretation of biological data using the combination of biologycomputer scienceinformation engineeringmathematics and statistics for others; computer assisted molecule design; identification of biological targetsnetworks and pathways; chemical and biological research and analysis; pharmaceutical research and development services; diagnostic and screening servicesconducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes to combat diseases
Classe 44
Medical diagnostic testing and medical screening services
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/03/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/06/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/04/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/04/2024
FIMP
FINAL DISPOSITION PROCESSED
10/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/10/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
25/10/2023
GPNX
NOTIFICATION PROCESSED BY IB
24/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2023
PUBO
PUBLISHED FOR OPPOSITION
24/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/08/2023
RFNT
REFUSAL PROCESSED BY IB
15/03/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/02/2023
RFRR
REFUSAL PROCESSED BY MPU
22/02/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/12/2022
CNRT
NON-FINAL ACTION WRITTEN
26/12/2022
DOCK
ASSIGNED TO EXAMINER
25/12/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/11/2022
MAFR
APPLICATION FILING RECEIPT MAILED
24/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/05/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/05/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXSCIENTIA DRIVEN BY KNOWLEDGE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.